Royce & Associates LP Corcept Therapeutics Inc Transaction History

Royce & Associates LP

  • $10.5 Billion
  • Q3 2024

A detailed history of Royce & Associates LP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Royce & Associates LP holds 363,272 shares of CORT stock, worth $18.5 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
363,272
Previous 350,272 3.71%
Holding current value
$18.5 Million
Previous $11.4 Million 47.66%
% of portfolio
0.16%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$29.51 - $46.26 $383,630 - $601,380
13,000 Added 3.71%
363,272 $16.8 Million
Q2 2024

Aug 13, 2024
BUY
$22.21 - $34.48 $310,940 - $482,719
14,000 Added 4.16%
350,272 $11.4 Million
Q1 2024

May 13, 2024
BUY
$21.1 - $27.46 $4,156 - $5,409
197 Added 0.06%
336,272 $8.47 Million
Q4 2023

Feb 12, 2024
SELL
$24.82 - $32.88 $422,659 - $559,913
-17,029 Reduced 4.82%
336,075 $10.9 Million
Q3 2023

Nov 09, 2023
BUY
$21.97 - $33.8 $1.3 Million - $2.01 Million
59,363 Added 20.21%
353,104 $9.62 Million
Q2 2023

Aug 07, 2023
SELL
$21.44 - $25.15 $268,278 - $314,701
-12,513 Reduced 4.09%
293,741 $6.54 Million
Q1 2023

May 04, 2023
BUY
$19.2 - $24.47 $898,176 - $1.14 Million
46,780 Added 18.03%
306,254 $6.63 Million
Q4 2022

May 23, 2023
SELL
$19.95 - $29.96 $933,261 - $1.4 Million
-46,780 Reduced 15.27%
259,474 $5.27 Million
Q4 2022

Feb 13, 2023
SELL
$19.95 - $29.96 $264,118 - $396,640
-13,239 Reduced 4.85%
259,474 $5.27 Million
Q3 2022

Nov 03, 2022
SELL
$24.7 - $29.12 $191,103 - $225,301
-7,737 Reduced 2.76%
272,713 $6.99 Million
Q2 2022

Aug 04, 2022
BUY
$17.33 - $25.3 $1,195 - $1,745
69 Added 0.02%
280,450 $6.67 Million
Q1 2022

May 05, 2022
BUY
$16.53 - $25.21 $3.76 Million - $5.73 Million
227,477 Added 429.98%
280,381 $6.31 Million
Q4 2021

Feb 07, 2022
BUY
$17.1 - $23.34 $52,001 - $70,976
3,041 Added 6.1%
52,904 $1.05 Million
Q3 2021

Nov 10, 2021
SELL
$19.68 - $22.53 $45,460 - $52,044
-2,310 Reduced 4.43%
49,863 $981,000
Q2 2021

Aug 06, 2021
SELL
$19.97 - $24.43 $5,391 - $6,596
-270 Reduced 0.51%
52,173 $1.15 Million
Q1 2021

May 10, 2021
SELL
$23.49 - $30.56 $205,772 - $267,705
-8,760 Reduced 14.31%
52,443 $1.25 Million
Q4 2020

Feb 08, 2021
SELL
$16.78 - $27.3 $25,220 - $41,031
-1,503 Reduced 2.4%
61,203 $1.6 Million
Q3 2020

Nov 12, 2020
SELL
$12.46 - $19.98 $7,102 - $11,388
-570 Reduced 0.9%
62,706 $1.09 Million
Q2 2020

Aug 07, 2020
SELL
$11.0 - $18.26 $23,815 - $39,532
-2,165 Reduced 3.31%
63,276 $1.06 Million
Q1 2020

May 12, 2020
SELL
$10.11 - $14.04 $12,849 - $17,844
-1,271 Reduced 1.91%
65,441 $778,000
Q4 2019

Feb 06, 2020
BUY
$12.06 - $16.96 $83,394 - $117,278
6,915 Added 11.56%
66,712 $807,000
Q3 2019

Nov 13, 2019
BUY
$10.41 - $14.66 $211,302 - $297,568
20,298 Added 51.39%
59,797 $845,000
Q2 2019

Aug 12, 2019
BUY
$9.78 - $12.76 $167,169 - $218,106
17,093 Added 76.29%
39,499 $440,000
Q1 2019

May 09, 2019
BUY
$10.03 - $15.71 $212,224 - $332,407
21,159 Added 1696.79%
22,406 $263,000
Q4 2018

Feb 11, 2019
SELL
$11.29 - $17.19 $4,188 - $6,377
-371 Reduced 22.93%
1,247 $17,000
Q3 2018

Nov 13, 2018
BUY
$12.27 - $15.65 $10,687 - $13,631
871 Added 116.6%
1,618 $23,000
Q2 2018

Aug 09, 2018
BUY
$15.3 - $19.69 $11,429 - $14,708
747 New
747 $12,000

Others Institutions Holding CORT

# of Institutions
346
Shares Held
86.1M
Call Options Held
1.12M
Put Options Held
667K
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.45B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email